Colinz Laboratories (531210.BO) Osake Kurssi

Colinz Laboratories Ltd. engages in the manufacture of pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectable, ointments, and creams. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2004-01-13. The firm is engaged in the manufacturing and marketing various allopathic and ayurvedic pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals and ointments, among others. The company provides physicians with products in the treatment of hypertension, cholesterol, diabetes, piles, pyrexia and malaria. The company provides gynecologists with specialized products in the treatments of morning sickness, infertility, intrauterine growth restriction (IUGR) and maintenance of pregnancy. The company also offers other products, such as hematinic, antispasmodics, anti-inflammatory/anti-allergic tablets, capsules gel and medicated shampoo. The firm markets its products in the states of Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, Madhya Pradesh, Chhattisgarh and West Bengal through its own marketing staff.